RxDoctor Payments Data

David Wages

Hematology · South Boroulh, MANPI 1962762203

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $453,962 of the $453,991 with a category attached, or 100.0%. AstraZeneca accounts for 68.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $177,262 and has fallen 100.0% since, to $29 in 2024. Among hematology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$453,991in general payments, 2019–2025

Across 35 payments — averaging $12,971 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$313K
  • Myovant Sciences Inc.$106K
  • Acerta Pharma LLC$28K
  • Sumitomo Pharma America, Inc.$5K
  • Verastem, Inc.$2K
  • Revance Therapeutics, Inc.$29

What the payments were for

  • Consulting fees$453,962100%
  • Food & beverage$290%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$453,991 in reported general payments places this provider in the 95th percentile of 77 hematology providers in Massachusetts.

See all hematology providers in Massachusetts

Other hematology in South Boroulh

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →